A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice

Diabetes

Volumn 55, Issue 2, 2006, Pages 356-366

  Inagi, Reiko ^a   Yamamoto, Yasuhiko ^b   Nangaku, Masaomi ^c   Usuda, Nobuteru ^d   Okamato, Hiroshi ^e   Kurokawa, Kiyoshi ^a   Van Ypersele De Strihou, Charles ^f   Yamamoto, Hiroshi ^b   Miyata, Toshio ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; 8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MEGSIN; PENTOSIDINE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; GENE OVEREXPRESSION; GLOMERULUS; INFLAMMATORY CELL; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; KIDNEY INJURY; MESANGIUM; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE TYPE II; SERPINS;

EID: 33644779814     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.55.02.06.db05-0702     Document Type: Article

References (24)

1. Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127-1133, 1999
2. Remuzzi G, Schieppati A, Ruggenenti P: Clinical practice: nephropathy in patients with type 2 diabetes. N Engl J Med 346:1145-1151, 2002
3. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H: Development and prevention of advanced diabetic nephropathy in RAGEoverexpressing mice. J Clin Invest 108:261-268, 2001
4. Miyata T, Nangaku M, Suzuki D, Inagi R, Uragami K, Sakai H, Okubo K, Kurokawa K: A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J Clin Invest 102:828-836, 1998
5. Inagi R, Nangaku M, Miyata T, Kurokawa K: Mesangial cell-predominant functional gene, megsin (Review). Clin Exp Nephrol 7:87-92, 2003
6. Suzuki D, Miyata T, Nangaku M, Takano H, Saotome N, Toyoda M, Mori Y, Zhang SY, Inagi R, Endoh M, Kurokawa K, Sakai H: Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. J Am Soc Nephrol 10:2606-2613, 1999
7. Inagi R, Nangaku M, Miyata T: Synergistic contribution of carbonyl stress and megsin: central players in diabetic nephropathy. Ann N Y Acad Sci 1043:605-608, 2005
8. Miyata T, Inagi R, Nangaku M, Imasawa T, Sato M, Izuhara Y, Suzuki D, Yoshino A, Onogi H, Kimura M, Sugiyama S, Kurokawa K: Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J Clin Invest 109:585-593, 2001
9. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
10. Malorny U, Michels E, Sorg C: A monoclonal antibody against an antigen present on mouse macrophages and absent from monocytes. Cell Tissue Res 243:421-428, 1986
11. Ohse T, Ota T, Kieran N, Godson C, Yamada K, Tanaka T, Fujita T, Nangaku M: Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritis. J Am Soc Nephrol 15:919-927, 2004
12. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T: Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42:31-38, 2003
13. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353-2358, 1996
14. ε-(carboxymethyl) hydroxylysine in human skin collagen. Biochemistry 30:1205-1210, 1991
15. Takamura T, Kato I, Kimura N, Nakazawa T, Yonekura H, Takasawa S, Okamoto H: Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. J Biol Chem 273:2493-2496, 1998
16. Yasuda Y, Miyata T, Nangaku M, Iida Y, Maeda K, Kurokawa K, Okubo K: Functional quantitative analysis of the genome in cultured human mesangial cells. Kidney Int 53:154-158, 1998
17. Nangaku M, Miyata T, Suzuki D, Umezono T, Hashimoto T, Wada T, Yagi M, Nagano N, Inagi R, Kurokawa K: Cloning of rodent megsin revealed its up-regulation in mesangioproliferative nephritis. Kidney Int 60:641-652, 2001
18. Inagi R, Miyata T, Suzuki D, Toyoda M, Wada T, Ueda Y, Izuhara Y, Sakai H, Nangaku M, Kurokawa K: Specific tissue distribution of megsin, a novel serpin, in the glomerulus and its up-regulation in IgA nephropathy. Biochem Biophys Res Commun 286:1098-1106, 2001
19. Fogo AB :Mesangial matrix modulation and glomerulosclerosis (Review). Exp Nephrol 7:147-159, 1999
20. Hruby Z, Wendycz D, Kopec W, Zielinski B, Paczek L, Soin J: Mechanism of antinephritic effect of proteinase inhibitors in experimental anti-GBM glomerulopathy. Res Exp Med (Berl) 199:295-307, 2000
21. 21. Johnson RJ, Lovett D, Lehrer RI, Couser WG, Klebanoff SJ: Role of oxidants and proteases in glomerular injury. Kidney Int 45:352-359, 1994
22. 22. Davies M, Martin J, Thomas GJ, Lovett DH: Proteinases and glomerular matrix turnover. Kidney Int 41:671-678, 1992
23. 23. Baricos WH, Shah SV: Proteolytic enzymes as mediators of glomerular injury. Kidney Int 40:161-173, 1991
24. 24. McLennan SV, Fisher EJ, Yue DK, Turtle JR: High glucose concentration causes a decrease in mesangium degradation: a factor in the pathogenesis of diabetic nephropathy. Diabetes 43:1041-1045, 1994